REFERENCES
Cardarelli, F., Digiacomo, L., Marchini, C., Amici, A., Salomone, F., Fiume, G., . . . Caracciolo, G. (2016). The intracellular trafficking mechanism of Lipofectamine-based transfection reagents and its implication for gene delivery. Sci Rep, 6 , 25879. doi:10.1038/srep25879
Cawood, R. (2020). Redefining AAV Manufacturing: The Time Is Now. Retrieved from https://www.genengnews.com/magazine/redefining-aav-manufacturing-the-time-is-now/
Chahal, P. S., Schulze, E., Tran, R., Montes, J., & Kamen, A. A. (2014). Production of adeno-associated virus (AAV) serotypes by transient transfection of HEK293 cell suspension cultures for gene delivery. J Virol Methods, 196 , 163-173. doi:10.1016/j.jviromet.2013.10.038
Clement, N., & Grieger, J. C. (2016). Manufacturing of recombinant adeno-associated viral vectors for clinical trials. Mol Ther Methods Clin Dev, 3 , 16002. doi:10.1038/mtm.2016.2
Erbacher, P., Bettinger, T., Brion, E., Coll, J. L., Plank, C., Behr, J. P., & Remy, J. S. (2004). Genuine DNA/polyethylenimine (PEI) complexes improve transfection properties and cell survival. J Drug Target, 12 (4), 223-236. doi:10.1080/10611860410001723487
Furuta-Hanawa, B., Yamaguchi, T., & Uchida, E. (2019). Two-Dimensional Droplet Digital PCR as a Tool for Titration and Integrity Evaluation of Recombinant Adeno-Associated Viral Vectors. Hum Gene Ther Methods, 30 (4), 127-136. doi:10.1089/hgtb.2019.031
Fus-Kujawa, A., Prus, P., Bajdak-Rusinek, K., Teper, P., Gawron, K., Kowalczuk, A., & Sieron, A. L. (2021). An Overview of Methods and Tools for Transfection of Eukaryotic Cells in vitro. Front Bioeng Biotechnol, 9 , 701031. doi:10.3389/fbioe.2021.701031
Hajba, L., & Guttman, A. (2020). Recent Advances in the Analysis Full/Empty Capsid Ratio and Genome Integrity of Adeno-associated Virus (AAV) Gene Delivery Vectors. Curr Mol Med, 20 (10), 806-813. doi:10.2174/1566524020999200730181042
Kerviel, A., Dash, S., Moncorge, O., Panthu, B., Prchal, J., Decimo, D., . . . Muriaux, D. (2016). Involvement of an Arginine Triplet in M1 Matrix Protein Interaction with Membranes and in M1 Recruitment into Virus-Like Particles of the Influenza A(H1N1)pdm09 Virus. PLoS One, 11 (11), e0165421. doi:10.1371/journal.pone.0165421
Kuzmin, D. A., Shutova, M. V., Johnston, N. R., Smith, O. P., Fedorin, V. V., Kukushkin, Y. S., . . . Johnstone, E. C. (2021). The clinical landscape for AAV gene therapies. Nat Rev Drug Discov, 20 (3), 173-174. doi:10.1038/d41573-021-00017-7
Nguyen, T. N. T., Sha, S., Hong, M. S., Maloney, A. J., Barone, P. W., Neufeld, C., . . . Braatz, R. D. (2021). Mechanistic model for production of recombinant adeno-associated virus via triple transfection of HEK293 cells. Mol Ther Methods Clin Dev, 21 , 642-655. doi:10.1016/j.omtm.2021.04.006
Reich, N. C., Sarnow, P., Duprey, E., & Levine, A. J. (1983). Monoclonal antibodies which recognize native and denatured forms of the adenovirus DNA-binding protein. Virology, 128 (2), 480-484. doi:10.1016/0042-6822(83)90274-x
Sharon, D., & Kamen, A. (2018). Advancements in the design and scalable production of viral gene transfer vectors. Biotechnol Bioeng, 115 (1), 25-40. doi:10.1002/bit.26461
Sharon, D. M., Nesdoly, S., Yang, H. J., Gelinas, J. F., Xia, Y., Ansorge, S., & Kamen, A. A. (2020). A pooled genome-wide screening strategy to identify and rank influenza host restriction factors in cell-based vaccine production platforms. Sci Rep, 10 (1), 12166. doi:10.1038/s41598-020-68934-y
Wang, D., Tai, P. W. L., & Gao, G. (2019). Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov, 18 (5), 358-378. doi:10.1038/s41573-019-0012-9
Wobus, C. E., Hugle-Dorr, B., Girod, A., Petersen, G., Hallek, M., & Kleinschmidt, J. A. (2000). Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection. J Virol, 74 (19), 9281-9293. doi:10.1128/jvi.74.19.9281-9293.2000
Xiao, W., Warrington, K. H., Jr., Hearing, P., Hughes, J., & Muzyczka, N. (2002). Adenovirus-facilitated nuclear translocation of adeno-associated virus type 2. J Virol, 76 (22), 11505-11517. doi:10.1128/jvi.76.22.11505-11517.2002
Xiong, W., MacColl Garfinkel, A. E., Li, Y., Benowitz, L. I., & Cepko, C. L. (2015). NRF2 promotes neuronal survival in neurodegeneration and acute nerve damage. J Clin Invest, 125 (4), 1433-1445. doi:10.1172/JCI79735
Zhao, H., Lee, K. J., Daris, M., Lin, Y., Wolfe, T., Sheng, J., . . . Meisen, W. H. (2020). Creation of a High-Yield AAV Vector Production Platform in Suspension Cells Using a Design-of-Experiment Approach.Mol Ther Methods Clin Dev, 18 , 312-320. doi:10.1016/j.omtm.2020.06.004